IRIDEX Trades Around $1 Following Holiday, Eye-Care Firm Faces Next Challenges
IRIDEX shares last traded at $1.01, valuing the company at about $17.5 million as U.S. markets reopened after Memorial Day. The firm reported Q1 revenue of $11.8 million and a net loss of $524,000, narrowing from $1.7 million a year earlier. Management kept its 2026 revenue target at $51 million to $53 million. Gross margin fell to 40% from 43% last year.
